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EXTENDED ABSTRACT 
In this paper, we reanalyze Medical Innovation, 
the classic study on diffusion of Tetracycline by 
Coleman, Katz and Menzel (1966). Medical 
Innovation articulates how different patterns of 
interpersonal communications can influence the 
diffusion process at different stages of adoption. 
In their pioneering study, individual network 
(discussion, friendship or advice) was perceived 
as a set of disjointed pairs, and the extent of 
influences were therefore, evaluated for pairs of 
individuals.  Given the existence of overlapping 
networks and consequent influences on doctors’ 
adoption decisions, the complexity of actual 
events was not captured by pair analysis. 
Subsequent reanalyses (Burt 1987, Strang and 
Tuma 1993,  Valente 1995, Van den Bulte and 
Lilien 2001) failed to capture the complexity 
involved in the diffusion process and had a static 
exposure of the network structure. In this paper, 
for the first time, we address these limitations by 
combining Agent-Based Modeling (ABM) and 
network analysis.  
Based on the findings of Coleman et. al. (1966) 
study, we develop a diffusion model, Gammanym. 
Using SMALLTALK programming language, 
Gammanym is developed with CORMAS 
platform under Visual Works environment. The 
medical community is portrayed in an 8 X 8 
spatial grid. The unit cell captures three different 
locations for professional interactions: practices, 
hospitals, and conference centers, randomly 
located over the spatial grid. Two social agents-
Doctor and Laboratory are depicted in the model. 
Doctors are the principal agents in the diffusion 
process and are initially located at their respective 
practices. A doctor’s adoption decision is 
influenced by a random friendship network, and a 
professional network created through discussions 
with office colleagues, or hospital visits or 
conference attendance. A communicating agent, 
Laboratory, on the other hand, influences doctors’ 
adoption decisions by sending information through 
multiple channels: medical representatives or 
detailman visiting practices, journals sent to 
doctors’ practices and commercial flyers available 
during conferences. Doctors’ decisions to adopt a 
new drug involve interdependent local interactions 
among different entities in Gammanym.  
The cumulative adoption curves (Figure 1) are 
derived for three sets of initial conditions, based on 
which network topology and evolution of uptake 
are analyzed. The three scenarios are specified to 
evaluate the degree of influences by different 
factors in the diffusion process: baseline scenario 
with one seed (initial adopter), one detailman and 
one journal; heavy media scenario with one seed 
but increasing degrees of external influence, with 
five detailman and four journals; and integration 
scenario with one seed, without any external 
influence from the laboratory.  
 
 
 
 
 
Figure 1: Cumulative Diffusion Curves for three 
scenarios: Baseline (Series 1), Heavy Media (Series 
2) and Integration (Series 3) 
Averaged over an ensemble of 100 runs, clustering 
coefficient and average shortest path length indicate 
that social networks depicted in Gammanym are 
random graphs. Evolution of uptake suggests that 
although the degree of external influence in terms 
of marketing strategies adopted by the 
pharmaceutical company does not have impact on 
the network structure, the speed of diffusion is 
largely determined by it.  
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1. INTRODUCTION 
In this paper we reanalyze Medical Innovation by 
Coleman et. al. (1966), the classic study on 
diffusion of Tetracycline, which at that time was a 
newly introduced antibiotic. Their pioneering 
study elaborated on how different patterns of 
interpersonal communications can influence the 
diffusion of a medical innovation in four medical 
communities in Illinois. The motivation for our 
reanalysis is to capture the complex interactions 
involved in the diffusion process by combining 
Agent-based Modeling (ABM) and network 
analysis. Based on the findings in Medical 
Innovation, we develop a diffusion model called 
Gammanym. The topology of networks generated 
in Gammanym, and its evolution, are analyzed to 
evaluate how, and to what extent, network 
structure influences the diffusion process.  
 
2. DIFFUSION AND NETWORKS 
2.1. Diffusion of Tetracycline 
Tetracycline was launched in November 1953. 
Four US Midwestern cities: Peoria, Bloomington, 
Quincy and Galesburg, were selected for the 
original study.  The sample constituted 148 general 
practitioners, internists, and pediatricians in active 
practice, of which 126 (85% of the sample) were 
interviewed. In an attempt to evaluate the 
importance of social networks, each of them was 
asked about their close associates (e.g., friends, 
colleagues and advisors) in the medical 
community. A prescription audit in the local 
pharmacies was carried out for 125 doctors (121 
general practitioners, internists, and pediatricians 
and 4, listed as surgeons or proctologists) over a 
16-month period following the release of 
Tetracycline for general sale. Prescriptions were 
edited for three successive days at approximately 
monthly intervals (Coleman et. al. 1966: 194).  
Their study identifies two broad categories of 
variables influencing the diffusion process. First 
category describes personal traits or individual 
variables, affecting individual receptivity: 1. type 
of practice, 2. medical background, 3. contacts 
with out-of-town institutions, 4. media behavior, 
and 5. orientations and attitudes. Second category 
defines social variables influencing the adoption 
process as a result of professional ties created 
through hospital affiliation and shared office, or 
social ties to other members of the community. 
Their analyses revealed that doctors’ decisions to 
adopt Tetracycline, the new drug, were strongly 
influenced by the people they are connected with, 
either socially or professionally.  
We have reviewed four reanalyses of Medical 
Innovation. The authors differed in terms of their 
methods as well as their perspectives on the 
process of diffusion. Burt (1987) argues that where 
contagion occurred, its effect was through 
structural equivalence not cohesion. Strang and 
Tuma (1993) apply an event-history framework 
incorporating spatial and temporal heterogeneity. 
Their results contradicts Burt, as they opine, 
“Cohesive ties based on advice giving and 
discussion also contribute to diffusion, as do 
structures of similarity in physicians’ orientation 
towards their work (Strang and Tuma 1993: 638).” 
Valente (1995) tests his threshold/critical mass 
(T/CM) model on medical innovation data and 
indicates that the opinion leaders, who have greater 
exposure to external influence, play a dominant 
role in the diffusion process. A study by Van den 
Bulte and Lilien (1999, 2001)  provides strong 
support for external influence in the diffusion 
process by incorporating a data set  on 
advertisement volume. The authors conclude that 
the data do not show that diffusion was driven by 
contagion operating over social networks, and that 
earlier analyses confounded social contagion with 
the effect of marketing effort (Van den Bulte and 
Lilien 2001).  
2.2. Rationale for Gammanym  
The major limitation of all the previous studies is 
their static exposition of network structure, which 
falls short of representing the evolving process. 
These dynamics can be described by the Dynamics 
of the network, or Dynamics on the network (Watts 
2003). Until now, however, neither medical 
innovation study nor the subsequent reanalyses of 
the original dataset incorporated any of those 
dynamic features. Our study, therefore 
complements the extant work.  
Our study also makes contribution in that the 
complexity generated in the diffusion process has 
not been examined by any previous studies. In 
Medical Innovation, the extent of influence was 
evaluated for pairs of individuals.  Individual 
network (discussion, friendship or advice) was, 
therefore, perceived as a set of disjointed pairs. 
Given the existence of overlapping networks and 
consequent influences on doctors’ adoption 
decisions, the complexity of actual events was not 
captured by pair analysis. ABM enables us to 
address this limitation in previous studies by 
considering the whole network as a unit of 
analysis. 
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3. MODELLING FRAMEWORK 
Using SMALLTALK programming language, we 
develop Gammanym with the CORMAS platform 
(Common-pool Resources and Multi-Agent 
Systems, http://cormas.cirad.fr) under Visual 
Works environment. 
3.1. Spatial Representation and Passive 
objects 
We portray the medical community in a 8 X 8 
spatial grid. The unit cell captures three different 
locations for professional interactions: Hospitals, 
Practices and Conference Center, which are 
created as Passive objects. Gammanym has sixty-
one practices, two hospitals and one conference 
center, randomly located over the spatial grid. In 
the original study, on average 47% of doctors were 
alone in office, 20% were in clinics, 17% were 
working with two colleagues and 15% were 
sharing office with one colleague. We captured the 
categories of office partnership into three practice 
types: Private (alone in office), Center (shared 
office with two partners) and Clinic (working with 
four colleagues). The doctors are thus located 
among 46 private, 11 centers and 4 clinics.  
Gammanym specifies two hospitals, as all the 
cities, on average, have two hospitals. Conference 
center, the third passive entity, provides the 
context in which a much larger group of 
professionals can interact with each other. Random 
allocation of these practices over the grid reflects 
that spatial representation is not sensitive to 
distances. In other words, the doctors’ decision to 
go to hospitals or the conference center, do not 
depend on the location of their practices; as the 
grid does not incorporate any Geographic 
Information System (GIS) specifications. This 
inclusion was not possible, as we do not have the 
original data set. GIS specifications, on the other 
hand, would add little to our analysis in the sense 
that the significance of physical distance in 
diffusing a new idea can, and is, well captured by 
our definition of discussion networks. Without GIS 
specifications real distance between cells have no 
impact on the doctors decision to move from office 
to hospitals or conference centers.  
3.2. Social agents 
Gammanym depicts two kinds of social agents- 
Doctor and Laboratory. Initially located in their 
respective practices, 99 doctors are created. A 
laboratory (LAB from hereon), on the other hand, 
influences doctors’ adoption decisions by sending 
information through multiple channels: medical 
representatives, journals and commercial flyers.  
3.2.1 Located and Communicating Agents: 
Doctors 
In Gammanym, Doctors are specified with the 
attributes generating network effects only. 
Individual traits have impacts on the adoption 
decision. Nevertheless, we opt for this 
simplification on the basis of the correlation 
coefficient estimated in medical innovation. Four 
network variables, shared office, advice seeking, 
discussion and friendship, showed a strong 
association to the date of first use of Tetracycline 
than any other individual variables, with the single 
exception of total volume of prescriptions for the 
class of drugs. Holding the volume of prescriptions 
constant, the association between integration and 
adoption increased (Coleman et. al. 1966: 92). 
Thus, we explore if all the doctors are homogenous 
in terms of their individual attributes, to what 
extent does integration matter for adoption 
decision?  
Professional interactions are spatially defined, 
based on which Gammanym builds discussion 
networks. We do this to signify the importance of 
tacit knowledge or non-codified knowledge, which 
requires face-to-face contacts for its transmission. 
The doctors, therefore, consider the others as 
discussion partners if they are situated in the same 
cell. After each visit to hospital or conference 
centers, doctors return back to their practices. The 
friendship network, on the other hand, is random 
in nature as the doctors are initialized with random 
number of friends and counter for friends; both 
ranging from 0-3. We treated the indices of 
similarity derived in the original study with 
reservation, because of their limited statistical 
relevance for only 111 friendship pairs (Coleman 
et. al.  1966: 143).  
3.2.2. Communicating Agents: Laboratory 
LAB adopts a mixed marketing strategy with three 
different channels to send information about the 
new drug: i. Detailman (pharmaceutical 
representative) visiting practices; ii. Flyers, 
available at the conferences; iii. Journals, sent to 
doctors’ practices. 
In Gammanym the detailman visits all the doctors 
at their practices. Assuming similar influences by 
direct mail advertising and journal insertions, we 
specify journals as the second instrument for the 
LAB. We introduce flyers at the conference centers 
as an additional marketing tool. To avoid the 
notion of blanket exposure to all doctors, we 
specify the criterion that LAB sends flyers based 
on the number of previous conference participants. 
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3.4 Adoption Process/Decision-making process 
Doctors’ decisions to adopt a new drug involve 
interdependent local interactions among different 
entities in Gammanym. Diffusion scholars have 
long recognized that individual’s decision about 
adoption is a process that occurs over time, 
consisting of several stages (Coleman et. al.  1966; 
Rogers 1995). We specify five stages of adoption: 
1. Awareness or knowledge, 2. Interest, 3. 
Evaluation/mental trial, 4. Trial, and 5. 
Adoption/acceptance. In our model readiness is 
specified as the attribute signifying the above 
stages of adoption. All doctors are initialized with 
readiness 4. Readiness is decremented when they 
receive an alert from different sources. 
Discussions with other doctors, either friends or 
colleagues at practices, conferences, or hospitals 
generate an alert when the mean adoption rate is 
0.50 or above. In case of the LAB, on the other 
hand, an alert is created each time a doctor 
received information from the detailman, flyers or 
journals. Doctors’ readiness is gradually reduced 
with alerts from all the aforementioned sources. 
When the readiness reaches zero 
(Adoption/acceptance stage), doctors adopt the 
new drug. 
3.5 Modeling Sequence 
Gammanym is divided into four phases: i) 
managing professional interactions; ii) external 
influence; iii) decision making process; and iv) 
networks formation. At each time step, 
Gammanym resets the attributes of the practices. 
Thus, the doctors are at their respective practices at 
the beginning of each simulation.  
Phase I entails the methods for doctors’ 
professional interactions. Primarily, the doctors 
interact with the office colleagues at their 
practices. Hospitals are another location for 
professional interactions, where they have their 
monthly visits. The third location for information 
exchange is the conference center, as the doctors 
move from their practices to there after receiving 
invitations. Phase II depicts the mixed marketing 
strategy adopted by the LAB. At each time step, 
the LAB targets practices from the unvisited ones 
and send the detailman if the doctors are available. 
After receiving an invitation for a conference from 
the conference center, the LAB sends flyers to the 
conference center based on number of previous 
conference attendees. LAB issues journals only 
when the number of newly adopted doctors in the 
previous time step, i.e., the last increment, is less 
than half of the average number of adopted 
doctors. Phase III is the decision-making process 
based on readiness. Phase IV constitutes the 
methods for network formation. At each time step, 
the network matrices for professional networks and 
friendship networks contain the number of 
interpersonal interactions for each doctor. The 
adoption matrix, on the other hand, specifies the 
adoption status at each time step for all the doctors.  
 
4. SIMULATION RESULTS 
In this section our discussion traces through the 
shape of the cumulative diffusion curves under 
three scenarios. The three scenarios are specified 
to evaluate the degree of influences by different 
factors in the diffusion process: i. Baseline 
Scenario; with one ‘seed’ or initial adopter, one 
detailman and one journal; ii. Heavy Media 
Scenario; with one initial adopter, five detailman 
and four journals; iii. Integration Scenario; one 
initial adopter, without any external influence from 
the LAB.  All three scenarios have been run over a 
68 weeks or 17 months which was the time length 
for original study. As several random functions are 
included in the algorithm, each scenario is repeated 
100 times in order to estimate the output’s 
variability. For each of the cases, the seed or the 
innovator is chosen among the doctors who are 
practicing at centers, i.e. doctors who have two 
colleagues.  
The cumulative diffusion curve (CDC), 
representing the total number of adopted doctors at 
each time step is shown in Figure 1. All three 
curves are derived after averaging over 100 
simulations.  Baseline scenario (Figure 1: Series 1) 
with one innovator and one detailman generated a 
logistic or S-shaped curve, similar to those found 
in cases of mixed influence diffusion models 
(Ryan and Gross 1943; Mahajan and Peterson 
1985; Rogers 1995; Valente 1993). In this 
scenario, our model reveals an adoption curve with 
an initial phase of slow diffusion until the first 
inflection point at the 24-time step where 23% of 
doctors have adopted the new drug. Thereafter, the 
rate of adoption speeds up as more doctors are 
exposed to someone who has already adopted and 
gradually begins to level off as fewer doctors 
remain in the population who are yet to adopt.  
The steepest diffusion curve (Figure 1: Series 2) 
represents a heavy media scenario, where 50% of 
the population adopts the new drug at the end of 
12 weeks. The rate of diffusion increases up to 16 
time steps and decreases afterwards as only 18% of 
doctors at that time have failed to adopt and 
remain unaffected. At the 25 time step, the CDC 
levels off as all the doctors have adopted the new 
drug. The integration scenario represents an 
extremely slow diffusion process (Figure 1: Series 
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3). As the only means to have an alert is to be in 
contact with the initial adopter, only 18% of the 
population adopt the new innovation at the end of 
68 times.  
5. NETWORK ANALYSIS 
5.1. Network Topology 
We first calculate the degree distribution to 
identify the class of networks the ABM interaction 
networks from four possible alternatives: (1) 
regular lattices; (2) random graphs (Erdös and 
Rényi 1959) (3) small world networks (Watts and 
Strogatz 1998); and (4) scale-free networks 
(Barabási 2002). Our simulations produce a degree 
distribution (Figure 2) that conforms to a binomial 
distribution, which suggests that the networks are 
most likely either a random graph, or a small 
world network (Watts 1999). 
 
Figure 2: Degree distribution created of the 
interaction networks in Gammanym 
A network is said to have small world properties 
if, compared to an Erdös-Rényi random graph, the 
following conditions hold: the average shortest 
path length, randPLPL ≈ ; and clustering 
coefficient, randCCCC >> . The comparison 
between the interaction networks generated by the 
simulation model, and an ensemble of random 
graphs reveals that randmodel PLPL ≈  and 
randmodel CCCC ≈ .  This suggests that the 
networks depicted in Gammanym are random 
graphs.  
5.2 Evolution of Networks  
The evolution of social networks in Gammanym 
has been analyzed to gain an understanding of the 
diffusion process. As agents interact with each 
other, new connections (relationships) form 
between agents, while others are reinforced. In 
order to study the nature and structure of clusters, 
we define a cluster as a set of agents that are 
connected.  That is, there exists a path from any 
agent to any other agent within that cluster. At 
each time step within the simulation we count the 
number of groups of agents and calculate the 
maximum, minimum, average cluster size, 
standard deviation in cluster size and the average 
shortest path length between agents within the 
system. All statistics were averaged over an 
ensemble of 100 runs. Figure 3 shows how the 
clusters of agents evolve over time.  
 
Figure 3: Network statistics. (A) Number of clusters; (B) Maximum cluster size; (C) Minimum cluster size; 
(D) Average cluster size; (E) Standard deviation in cluster size; (F) Average shortest path-length. 
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From Figure 3, we see that initially the simulation 
contains approximately 60 clusters of agents 
(Figure 3A).  As new interactions occur, the 
number of clusters quickly decays. Similarly, the 
maximum cluster size grows rapidly (Figure 3B).  
The minimum and average cluster sizes quickly 
explode as the agents become consumed by the 
giant cluster (Figures 3(C–D)). The system begins 
to behave as one giant cluster after about 7–10 
time steps. The standard deviation in cluster size is 
maximized just before the emergence of a fully 
connected system (Figure 3E). We note that the 
average shortest path length between nodes 
initially increases rapidly, as more and more nodes 
become connected to the giant cluster. When the 
system becomes connected, such that there exists a 
path between all agents, the average shortest path-
length between any two nodes is on average is 
relatively long. This is because of the sparsity of 
interaction matrices and the network containing 
many long paths.  However, as the system 
increases in connectivity the path-lengths become 
smaller until there is approximately two degrees of 
separation between any two agents within the 
system (Figure 3F). In short, the system initially 
consists of a number of disconnected components,  
but quickly evolves to form a single connected 
component 
5.3 Evolution of Uptake 
To analyze the differences in the speed of diffusion 
depicted in Section 4, we can look at how 
Tetracycline uptake evolves under three scenarios. 
We, therefore, define an uptake cluster as a set of 
agents who are connected to each other and each 
agent has adopted Tetracycline. In this context the 
uptake cluster can be thought of as a cluster 
commonly encountered in percolation studies 
(Stauffer 1979). Figure 4 shows how the uptake of 
Tetracycline evolves through time. In the base 
scenario, starting from one seed (innovator) the 
average number of uptake clusters increases up to 
1.6 at time step 15 (Figure 4A). Then, it decreases 
to one giant cluster (time step 30) as the size of the 
existing clusters increases gradually before 
merging. In Figure 4 (A) we also observe that the 
number of uptake clusters explodes rapidly under 
the heavy media scenario (Figure 4A). Under 
integration scenario, one average, only one uptake 
cluster is formed during 68 time steps (Figure 4D) 
and its maximum size  (Figure 4B) barley reaches 
20 at the end of simulation.  
Figure 4:  Uptake clusters for three scenarios (A) Number of clusters within the system; (B) Maximum 
cluster size; (C) Minimum cluster size; (D) Average cluster size; and (E) Standard deviation of cluster size.
6. CONCLUSIONS 
We develop an agent-based model, called 
Gammanym, to analyze the diffusion process. This 
is inspired by the classic Medical Innovation study 
on the adoption of Tetracycline in the Midwestern 
US in 1950s by Coleman et.  al. (1966). Due to the 
limited availability of proper technique or methods 
during 1950s, the original study focused on 
interpersonal influence for pairs of individuals. 
This approach, however, fails to capture the 
complexity and dynamics of actual adoptions. In 
our study, we overcome this limitation using 
agent-based modeling to consider the whole 
network as a unit of analysis. Our model brings 
original features within the existing literature of 
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diffusion research and also complements the extant 
work on medical innovation. 
In our study we also examine the diffusion process 
by applying the core concepts of network theory. 
On the basis of network properties we determine 
that the interaction networks depicted in the model 
are random graphs. Complexity of the diffusion 
process is explained by analyzing evolution of 
networks or dynamics on the networks. We find 
that initially the system consisted of a number of 
disconnected components and quickly evolves, 
after 7-10 time steps, to form a single connected 
component. The analysis of network topology also 
indicates that underlying networks evolve in 
predictable ways, and the uptake is a function of 
initial starting condition.  
Analyses of the evolution of uptake and adoption 
of Tetracycline enable us to disentangle the extent 
of different factors affecting adoption. Despite 
stressing the complementarity between network 
theory and diffusion research, a large body of 
diffusion literature has so far failed to examine the 
dynamic structures of the interpersonal networks 
and their evolutions over the diffusion process. 
Our model shows that although the media does not 
influence the network structure, it does have a 
major impact in accelerating the diffusion process.  
Under a heavy media exposure undertaken by the 
pharmaceutical company to increase sale of 
Tetracycline, the average size of clusters with 
agents who have adopted the new drug rise faster 
than otherwise. Moreover, all the agents adopt the 
new drug within 25 time steps, much earlier than 
that with a baseline scenario with much less media 
exposure.  
We also compare the cumulative diffusion curves 
of Gammanym with those of medical innovation. 
The cumulative diffusion curve under the heavy 
media scenario with initial speedy diffusion 
resembles more the one in the original study, 
compared to that of the typical S-shaped diffusion 
curve generated under baseline scenario or mixed 
influence diffusion. In conclusion, our results 
provide support to the importance of social 
networks in the diffusion process, but also show 
that external influences play a dominant role in 
speeding up the rate of adoption. 
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